LENSAR, Inc. (LNSR)

5.67 +0.44 (+8.41%) USD  |  NASDAQ  |  May 08, 16:00
5.67 0.00 (0.00%) After-Hours: 20:00
More

LENSAR Research and Development Expense (Annual) : 5.622M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for LNSR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Zomedica Corp. 7.166M
Intelligent Bio Solutions, Inc. 2.396M
Butterfly Network, Inc. 36.26M
Adagio Medical Holdings, Inc. 10.64M
NeuroPace, Inc. 27.89M